153 related articles for article (PubMed ID: 27848185)
61. [Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: 2 new cases].
Guillén M; Madero L; Parra L; Hernández C; Herrero B; Carceller F; Lassaletta A; Sevilla J
An Pediatr (Barc); 2013 Jun; 78(6):393-7. PubMed ID: 23182617
[TBL] [Abstract][Full Text] [Related]
62. Behcet disease in adult Druzes in north Israel: the influence of ethnic origin on disease expression and severity.
Rozenbaum M; Boulman N; Slobodin G; Zisman D; Mader R; Yankevitch A; Weinberger A; Rosner I
J Clin Rheumatol; 2007 Jun; 13(3):124-7. PubMed ID: 17551376
[TBL] [Abstract][Full Text] [Related]
63. Transplant for MDS: challenges and emerging strategies.
Tamari R; Castro-Malaspina H
Best Pract Res Clin Haematol; 2015 Mar; 28(1):43-54. PubMed ID: 25659729
[TBL] [Abstract][Full Text] [Related]
64. Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina.
Basquiera AL; Pizzi S; Correas AG; Longo PG; Goldman WC; Prates MV; Formisano S; Kusminisky G; Feldman L; Berretta AR; García JJ; Staciuk R
Pediatr Blood Cancer; 2015 Jan; 62(1):153-7. PubMed ID: 25264233
[TBL] [Abstract][Full Text] [Related]
65. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
[TBL] [Abstract][Full Text] [Related]
66. Pediatric-onset Behçet disease in Bahrain: report of nine cases and literature review.
Al Mosawi ZS; Madan W; Fareed E
Arch Iran Med; 2012 Aug; 15(8):485-7. PubMed ID: 22827784
[TBL] [Abstract][Full Text] [Related]
67. Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.
Scott BL; Storer B; Loken MR; Storb R; Appelbaum FR; Deeg HJ
Biol Blood Marrow Transplant; 2005 Jan; 11(1):65-73. PubMed ID: 15625546
[TBL] [Abstract][Full Text] [Related]
68. Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.
Saure C; Schroeder T; Zohren F; Groten A; Bruns I; Czibere A; Galonska L; Kondakci M; Weigelt C; Fenk R; Germing U; Haas R; Kobbe G
Biol Blood Marrow Transplant; 2012 Mar; 18(3):466-72. PubMed ID: 21963618
[TBL] [Abstract][Full Text] [Related]
69. Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.
Dan C; Chi J; Wang L
Ann Med; 2015 May; 47(3):209-17. PubMed ID: 25861829
[TBL] [Abstract][Full Text] [Related]
70. [Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies].
Nakamura Y; Mori T; Kato J; Aisa Y; Nakazato T; Shigematsu N; Okamoto S
Rinsho Ketsueki; 2012 Mar; 53(3):318-22. PubMed ID: 22499048
[TBL] [Abstract][Full Text] [Related]
71. Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study.
Woods WG; Kobrinsky N; Buckley J; Neudorf S; Sanders J; Miller L; Barnard D; Benjamin D; DeSwarte J; Kalousek D
J Clin Oncol; 1993 Aug; 11(8):1448-57. PubMed ID: 8336184
[TBL] [Abstract][Full Text] [Related]
72. Epidemiology of visceral mycoses in patients with acute leukemia and myelodysplastic syndrome: Analyzing the national autopsy database in Japan.
Togano T; Suzuki Y; Nakamura F; Tse W; Kume H
Med Mycol; 2021 Jan; 59(1):50-57. PubMed ID: 32400871
[TBL] [Abstract][Full Text] [Related]
73. The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.
Devillier R; Crocchiolo R; Castagna L; Fürst S; El Cheikh J; Faucher C; Prebet T; Etienne A; Chabannon C; Vey N; Esterni B; Blaise D
Bone Marrow Transplant; 2012 May; 47(5):639-45. PubMed ID: 22307016
[TBL] [Abstract][Full Text] [Related]
74. Chemotherapy for myeloid malignancy in children with Fanconi anemia.
Mehta PA; Ileri T; Harris RE; Williams DA; Mo J; Smolarek T; Auerbach AD; Kelly P; Davies SM
Pediatr Blood Cancer; 2007 Jun; 48(7):668-72. PubMed ID: 16609946
[TBL] [Abstract][Full Text] [Related]
75. Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Group.
Schroeder T; Rachlis E; Bug G; Stelljes M; Klein S; Steckel NK; Wolf D; Ringhoffer M; Czibere A; Nachtkamp K; Dienst A; Kondakci M; Stadler M; Platzbecker U; Uharek L; Luft T; Fenk R; Germing U; Bornhäuser M; Kröger N; Beelen DW; Haas R; Kobbe G
Biol Blood Marrow Transplant; 2015 Apr; 21(4):653-60. PubMed ID: 25540937
[TBL] [Abstract][Full Text] [Related]
76. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
Shin SH; Kim JH; Jeon YW; Yoon JH; Yahng SA; Lee SE; Choi YS; Kim DY; Lee JH; Lee S; Kim HJ; Min CK; Lee JW; Lee KH; Min WS; Kim YJ; Lee JH
Biol Blood Marrow Transplant; 2015 Feb; 21(2):342-9. PubMed ID: 25459640
[TBL] [Abstract][Full Text] [Related]
77. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia.
Bitan M; Or R; Shapira MY; Resnick IB; Gesundheit B; Ackerstein A; Samuel S; Elad S; Slavin S
Bone Marrow Transplant; 2008 Jan; 41(1):69-78. PubMed ID: 17994125
[TBL] [Abstract][Full Text] [Related]
78. Children With Behçet Disease-associated Thrombosis: A Single-Center Experience.
Guzelkucuk Z; Gurlek Gokcebay D; Arman Bilir O; Basaran O; Celikel Acar B; Ozbek NY; Yarali N
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e15-e18. PubMed ID: 32604332
[TBL] [Abstract][Full Text] [Related]
79. Intestinal Behçet's disease: a case report and review of Japanese reports in children.
Tabata M; Tomomasa T; Kaneko H; Morikawa A
J Pediatr Gastroenterol Nutr; 1999 Oct; 29(4):477-81. PubMed ID: 10512413
[No Abstract] [Full Text] [Related]
80. Gastrointestinal Involvement in Behçet Disease.
Hatemi I; Hatemi G; Çelik AF
Rheum Dis Clin North Am; 2018 Feb; 44(1):45-64. PubMed ID: 29149927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
